Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Autologous Platelet-Rich Plasma in Enhancing Episiotomy Wound Healing and Reducing Postpartum Perineal Pain: A Prospective Randomized Controlled Trial (PRP-EpiHeal)

NCT07669285 is registered in ClinicalTrials.gov with Saint Andrew Hospital Constanta as lead sponsor.

NCT NCT07669285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07669285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Autologous Platelet-Rich Plasma in Enhancing Episiotomy Wound Healing and Reducing Postpartum Perineal Pain: A Prospective Randomized Controlled Trial (PRP-EpiHeal)
Lead sponsor
Saint Andrew Hospital Constanta
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 21, 2026
Completion date
December 30, 2028
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

episiotomy, obstetric, platelet rich plasma (prp), wound healing